The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Isoprostanes: Potential Markers of Oxidant Stress in Atherothrombotic Disease
Open accessAbstract
Abstract Isoprostanes are emerging as a new class of biologically active products of arachidonic acid metabolism of potential relevance to human vascular disease. Their formation in vivo seems to reflect primarily, if not exclusively, a nonenzymatic process of lipid peroxidation. Enhanced urinary excretion of 8-iso-PGF 2α has been described in association with cardiac reperfusion injury and with cardiovascular risk factors, including cigarette smoking, diabetes mellitus, and hypercholesterolemia. Besides providing a likely noninvasive index of lipid peroxidation in these settings, measurements of specific F 2 isoprostanes in urine may provide a sensitive biochemical end point for dose-finding studies of natural and synthetic inhibitors of lipid peroxidation. Although the biological effects of 8-iso-PGF 2α in vitro suggest that it and other isoeicosanoids may modulate the functional consequences of lipid peroxidation, evidence that this is likely in vivo remains inadequate at this time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“F2-isoprostanes are generated from arachidonic acid through a process of nonenzymatic free radical-catalyzed lipid peroxidation, thus representing an established marker of oxidative stress.33”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.
Hámberg, M., Svensson, J., & Samuelsson, B. O. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.8.2994 · Cited by 3,045
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Stephens, N. G., Parsons, A., Brown, M. J., Schofield, P. M., Kelly, F., Cheeseman, K., & Mitchinson, M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90866-1 · Cited by 2,148
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
Smith, W. L., Garavito, R. M., & DeWitt, D. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.52.33157 · Cited by 1,973
Morrow, J. D., Hill, K. E., Burk, R. F., Nammour, T., Badr, K. F., & Roberts, L. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9383 · Cited by 1,898
Tuomilehto, J., Vidgrén, G., Toivanen, L., Tuomilehto‐Wolf, E., Kohtamäki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M. J., & Koskela, P. U. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,691
The role of oxidized lipoproteins in atherogenesis
Berliner, J. A., & Heinecke, J. W. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)02173-6 · Cited by 1,369
Research works printed but not linked: 21
- 10.1161/atvb.16.7.831 · DOI
- 10.1161/circ.67.6.6342834 · DOI
- 10.1161/circ.80.5.2553296 · DOI
- 1986, Am J Physiol, 250, H372
- 10.1161/res.65.3.2548761 · DOI
- 10.1161/circ.86.6.1451239 · DOI
- 1997, Circulation, 96, 2492
- Reilly MP Delanty N O’Callaghan P Crean P Roy L FitzGerald GA. Increased generation of the F 2 isoprostanes IPF 2α -1 and 8-iso-PGF 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation . In press.
- 1995, J Invest Med, 43, 292A
- 10.1161/str.25.2.8303731 · DOI
- 10.1161/circ.94.1.19 · DOI
- 1996, J Invest Med, 44, 223A
- Ciabattoni G Consoli A Vitacolonna E Mezzetti A Santarone S Pennese E Falco A Davi G Patrono C. In vivo formation of 8-epi-prostaglandin F 2α in diabetes mellitus: effects of tight metabolic control and vitamin E supplementation. Thromb Haemost . In press. Abstract.
- Davi G Alessandrini P Mezzetti A Minotti G Bucciarelli T Constantini F Cipallone F Bittolo Bon G Ciabattoni G Patrono C. In vivo formation of 8-epi-PGF 2α is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol . In press.
- Palinski W Witztum JL. Oxidative stress and diabetes mellitus. In: Schwartz CJ Born GVR eds. New Horizons in Diabetes Mellitus and Cardiovascular Disease . Rapid Science Publishers; 1996:81-93.
- 1992, Diabetes, 4, 61
- 10.1161/circ.87.6.8504494 · DOI
- 1994, Lancet, 344, 1383
- 1994, Nutrition, 10, 527
- 10.1161/circ.94.10.2434 · DOI
- 1995, J Biol Chem, 269, 17273
Cited by
Sorted by citations
Items 301–400 of 450
Krauss, E., Froehler, M., Degen, M., Mahavadi, P., Dartsch, R. C., Korfei, M., Ruppert, C., Seeger, W., & Günther, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050643 · Cited by 19
“It has also been shown to contract human smooth muscle cells from the lungs in vitro and to increase platelet activity [26,27].”
BackgroundBoldeanu, L., Văduva, C.-C., Caragea, D. C., Novac, M. B., Manasia, M., Siloşi, I., Manolea, M. M., Boldeanu, M. V., & Dijmărescu, A. L. (2023) · Life · doi:10.3390/life13122242 · Cited by 18
“8-iso-PGF2 α is one of the isoprostanes that are easily detectable, persistent in bodily fluids, unaffected by food, and controlled by endogenous antioxidants [45–47].”
BackgroundA potential role of PUFAs and COXIBs in cancer chemoprevention
Vara-Messler, M., Buccellati, C., Pustina, L., Folco, G., Rovati, G. E., & Hoxha, M. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.04.003 · Cited by 17
Determinants of platelet activation in hypertensives with microalbuminuria
Guagnano, M. T., Ferroni, P., Santilli, F., Paoletti, V., Manigrasso, M. R., Pescara, L., Cuccurullo, C., Ciabattoni, G., & Davı̀, G. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.01.005 · Cited by 18
Santos, M. T., Vallés, J., Aznar, J., Lago, A. P., Sánchez, E., Cosín, J., Moscardó, A., Piñón, M., Broekman, M. J., & Marcus, A. J. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.12.005 · Cited by 18
Inhibition of Lipoprotein Lipid Oxidation
Cynshi, O., & Stocker, R. (2005) · Handbook of experimental pharmacology · doi:10.1007/3-540-27661-0_21 · Cited by 16
Leonibus, C. D., Giannini, C., Corazzini, V., Chiarelli, F., & Mohn, A. (2012) · Free Radical Research · doi:10.3109/10715762.2011.653967 · Cited by 17
Coppola, A., D’Angelo, A., Fermo, I., Mazzola, G., Minno, M. N. D. D., Cajani, A., Sala, A., Folco, G., Tremoli, E., & Minno, G. D. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05732.x · Cited by 17
“…(PG) F2-like compounds produced from arachidonic acid through a non-enzymatic process of lipid peroxidation, catalysed by oxygen free radicals on cell membranes and low density lipoprotein particles (Patrono & FitzGerald, 1997), can be reliably measured in plasma and urine (Awad et al, 1993).”
BackgroundCrosta, F., Stefani, A., Melani, F., Fabrizzi, P., Nizzardo, A., Grassi, D., Bocale, R., Necozione, S., Lombardi, F., Castelli, V., et al. (2020) · Nutrients · doi:10.3390/nu13010056 · Cited by 18
“Furthermore, lipid peroxidation products are able to promote several vascular responses, including sustained vasoconstriction [72], platelet activation [73], and vascular inflammation [74], which could play a role in reducing brain tissue perfusion.”
BackgroundBiological Antioxidant Potential Negatively Correlates With Carotid Artery Intima-Media Thickness
Yagi, H., Sumino, H., Yoshida, K., Aoki, T., Tsunekawa, K., Araki, O., Kimura, T., Nara, M., Nakajima, K., & Murakami, M. (2016) · International Heart Journal · doi:10.1536/ihj.15-389 · Cited by 16
Activated intrarenal reactive oxygen species and renin angiotensin system in IgA nephropathy.
Ohashi, N., Urushihara, M., & Kobori, H. (2009) · PubMed · Cited by 16
Hypercholesterolemia, oxidative stress and gender dependence in children.
Ondrejovičová, I., Muchová, J., Mišľanová, C., Nagyová, Z., & Ďuračková, Z. (2010) · PubMed · Cited by 16
Production of 8-epi prostaglandin F2α in human platelets during administration of organic nitrates
McGrath, L. T., Dixon, L., Morgan, D. R., & McVeigh, G. E. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02037-5 · Cited by 16
The postprandial effects of dietary antioxidants in humans
Kay, C. D., & Holub, B. J. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0035-9 · Cited by 16
THE PHARMACOLOGY OF ANTITHROMBOTIC AND ANTIPLATELET AGENTS
Abu-Hajir, M., & Mazzeo, A. J. (1999) · Anesthesiology Clinics of North America · doi:10.1016/s0889-8537(05)70132-2 · Cited by 16
Marco, M. D., Urbano, F., Filippello, A., Mauro, S. D., Scamporrino, A., Miano, N., Coppolino, G., L’Episcopo, G., Leggio, S., Scicali, R., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102870 · Cited by 16
“, the F2 isoprostane 8-iso-PGF2α can be produced as a minor product of the cyclooxygenase activity of platelets in response to platelet stimulation with collagen, thrombin or arachidonate, and it is also a marker of oxidative stress [18,19].”
BackgroundHuang, S.-W., Kuo, H.-L., Hsu, M.-T., Tseng, Y. J., Lin, S., Kuo, S., Peng, H.-C., Lien, J., & Huang, T. (2016) · Thrombosis and Haemostasis · doi:10.1160/th15-12-0993 · Cited by 15
“These isoprostanes such as 8-iso-PGF2α has been reported to induce vasoconstriction and amplify the response of platelets to other agonists through TP receptor-mediated signalling (48).”
BackgroundDesideri, G., Bocale, R., Milardi, D., Ghiadoni, L., Grassi, D., Necozione, S., Taddei, S., di Orio, F., Pontecorvi, A., & Ferri, C. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03485.x · Cited by 15
Morita, H., Saito, Y., Kurabayashi, M., & Nagai, R. (2002) · Journal of Hypertension · doi:10.1097/00004872-200201000-00009 · Cited by 15
Oxidative DNA Damage is Induced by Chronic Cigarette Smoking, but Repaired by Abstention
Inoue, T., Hayashi, M., Takayanagi, K., & Morooka, S. (2003) · Eisei kagaku · doi:10.1248/jhs.49.217 · Cited by 15
The Role of Platelets in Diabetes Mellitus
Santilli, F., Simeone, P., & Liani, R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813456-6.00027-8 · Cited by 14
Lupoli, R., Minno, A. D., Spadarella, G., Franchini, M., Sorrentino, R., Cirino, G., & Minno, G. D. (2015) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0035-1549848 · Cited by 14
Jofre‐Monseny, L., Huebbe, P., Stange, I., Boesch, C., Frank, J., Jackson, K. G., Minihane, A. M., & Rimbach, G. H. (2008) · British Journal Of Nutrition · doi:10.1017/s000711450788634x · Cited by 14
“Isoprostanes are chemically stable PG isomers that result from oxidative modification of arachidonic acid through a mechanism catalysed by free radicals, and are used as markers of oxidative stress and lipid peroxidation((46)).”
BackgroundKim, M., Kim, M., Yoo, H. J., Yun, R., Lee, S.-H., & Lee, J. H. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.11.001 · Cited by 14
Papanikolaou, J., Ntalapascha, M., Makris, D. A., Koukoubani, T., Tsolaki, V., Zakynthinos, G. Ε., Gourgoulianis, K. I., & Zakynthinos, E. G. (2019) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753466619880076 · Cited by 12
Protection from chemotherapy‐induced alopecia by docosahexaenoic acid
Takahata, K., Tada, M., Yazawa, K., & Tamaki, T. (1999) · Lipids · doi:10.1007/bf02562249 · Cited by 13
LDL-apheresis decreases plasma levels and urinary excretion of 8-epi-PGF2α
Oguogho, A., Ferlitsch, A., & Sinzinger, H. F. (2000) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0145 · Cited by 13
Toyokuni, S., Masumizu, T., Ozeki, M., Kondo, S., Hiroyasu, M., Kohno, M., & Hiai, H. (2001) · Free Radical Research · doi:10.1080/10715760100300781 · Cited by 13
Tripathi, T., & Rasheed, Z. (2010) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657326 · Cited by 13
Heinecke, J. W. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0001-2 · Cited by 13
Brunetti, L., Orlando, G., Michelotto, B., Recinella, L., Nisio, C. D., Ciabattoni, G., & Vacca, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)02037-4 · Cited by 12
Virgin olive oil: a key healthy component of the Mediterranean diet
Mataix, J., Battino, M. A., Ramírez-Tortosa, M. C., Bertoli, E., & Quiles, J. L. (2008) · Mediterranean Journal of Nutrition and Metabolism · doi:10.1007/s12349-008-0012-5 · Cited by 12
Fluvastatin Increases LDL Particle Size and Reduces Oxidative Stress in Patients with Hyperlipidemia
Yoshino, G., Hirano, T., Kazumi, T., 竹本昌代, & Ohashi, N. (2003) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.10.343 · Cited by 12
Stanton, A. V., Fitzgerald, D., Hughes, A. D., Mayet, J., O’Brien, E., Poulter, N. R., Sever, P. S., Shields, D. C., & Thom, S. (2001) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001089 · Cited by 12
Exhaled Breath Marker in Asthma Patients with Gastroesophageal Reflux Disease
Shimizu, Y., Dobashi, K., & Mori, M. (2007) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.2007020 · Cited by 11
“Among the isoprostanes, 8-isoprostane (8-iso) has been reported as a tissue marker of oxidative stress [31].”
BackgroundA Phase I Study of Vitamin E, 5-Fluorouracil and Leucovorin for Advanced Malignancies
Blanke, C. D., Stipanov, M. A., Morrow, J. D., Rothenberg, M. L., Chinery, R., Shyr, Y., Coffey, R., Johnson, D. H., Leach, S. D., & Beauchamp, R. D. (2001) · Investigational New Drugs · doi:10.1023/a:1006484031959 · Cited by 11
“They are an accurate measurement of lipid peroxidation and might correlate with vitamin E potentiation of 5-FU/LCV anti-tumor activity [14,15].”
BackgroundRelative antioxidant deficiency in obese children: A weighty contributor to morbidity?
Lavine, J. E. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70401-4 · Cited by 9
Zhao, Z., Xu, Z., Le, K., Azordegan, N., Riediger, N. D., & Moghadasian, M. H. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900090q · Cited by 10
Carnevali, S., Buccellati, C., Bolego, C., Bertinaria, M., Rovati, G. E., & Sala, A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170602083428 · Cited by 10
Revascularization decreases 8-isoprostaglandin F2α excretion in chronic lower limb ischemia
Rossi, P., Riutta, A., Kuukasjärvi, P., Vehmas, T. I., Mucha, I., & Salenius, J. ‐. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.01.003 · Cited by 10
Antioxidants and coronary artery disease
Catapano, A. L., & Tragni, E. (1999) · Current Atherosclerosis Reports · doi:10.1007/s11883-999-0036-4 · Cited by 10
Effects of Kakisu (Persimmon Vinegar) on Plasma Antioxidant Power and Urinary 8-Isoprostane Level
Mure, K., Takeshita, T., Morioka, I., & Arita, M. (2007) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.62.32 · Cited by 8
Iodinated radiographic contrast media possess antioxidant properties in vitro
Berg, K., Skarra, S., Bruvold, M., Brurok, H., Karlsson, J., & Jynge, P. (2005) · Acta Radiologica · doi:10.1080/02841850500336224 · Cited by 9
“8-iso-PGF2a is commonly used as a biomarker of lipid peroxidation (7, 32), but is also known as a bioactive agent and potent vasoconstrictor (10, 37).”
BackgroundSarabi, M., Vessby, B. O., Basu, S., Millgård, J., & Lind, L. (1999) · Journal of Vascular Research · doi:10.1159/000025691 · Cited by 9
Glutathione sodium salt as a novel adjunctive treatment for acute myocardial infarction
Truscelli, G., Tanzilli, G., Viceconte, N., Dominici, M., Arrivi, A., Sommariva, L., Granatelli, A., Gaudio, C., & Mangieri, E. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.03.010 · Cited by 8
Teramoto, S., Suzuki, M., Matsuse, T., Ishii, T., Fukuchi, Y., & Ouchi, Y. (2000) · The Japanese Journal of Pharmacology · doi:10.1016/s0021-5198(19)30627-4 · Cited by 8
Gauthier, K. M., Campbell, W. B., & McNeish, A. J. (2014) · PeerJ · doi:10.7717/peerj.414 · Cited by 8
“These findings may have important implications in diseases associated with loss of NO signaling such as stroke and coronary artery disease where increased isoprostane production has been detected ( Patrono & FitzGerald, 1997 ).”
Effects of varying doses of testosterone on atherogenic markers in healthy younger and older men
Roberts, C. K., Chen, B. H., Pruthi, S., & Lee, M. L. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00372.2013 · Cited by 8
Yoshino, G., Tanaka, M., Nakano, S., Matsumoto, T., Kojima, M., Murakami, E., & Morita, T. (2009) · Current Therapeutic Research · doi:10.1016/j.curtheres.2009.12.003 · Cited by 8
PATRONO, C. (2002) · European Heart Journal Supplements · doi:10.1016/s1520-765x(02)90072-6 · Cited by 8
Self-citationDesideri, G., Bocale, R., D'Amore, A., Necozione, S., Boscherini, M., Carnassale, G., Barini, A., Barini, A., Bellantone, R., & Lombardi, C. P. (2017) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.07.002 · Cited by 7
“Circulating levels of 8-isoprostaglandin F 2α (8-iso-PGF2α), as an index of lipid peroxidation, was also eval uated due to the influential role of lipid oxidation products on pla telet activation and proatherogenic inflammation [19].”
BackgroundGrassi, D., Mai, F., Feo, M. D., Barnabei, R., Carducci, A., Desideri, G., Necozione, S., Allegaert, L., Bernaert, H., & Ferri, C. (2023) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-023-00571-8 · Cited by 8
Cigarette smoking and oxidative stress
Nowak, A., & Pawliczak, R. (2022) · Alergologia Polska - Polish Journal of Allergology · doi:10.5114/pja.2022.116285 · Cited by 7
Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
Lin, Y.-W., Tsai, C., Huang, C., Tsai, Y., Shih, C.-M., Lin, S., Li, C., Lin, C., Sung, S.-Y., & Lin, F. (2022) · Biomedicines · doi:10.3390/biomedicines10051089 · Cited by 7
“Additionally, FIR therapy reduces plasma levels of lipid peroxidation and 8-epi-prostaglandin F2α [47].”
BackgroundFetal metabolic adaptations to cardiovascular stress in twin-twin transfusion syndrome
Parchem, J. G., Fan, H., Mann, L. K., Chen, Q., Won, J. H., Gross, S. S., Zhao, Z., Taegtmeyer, H., & Papanna, R. M. (2023) · iScience · doi:10.1016/j.isci.2023.107424 · Cited by 7
Lactoferrin Effect on Lymphocyte Cytokines and Apoptosis Is Independent of Exercise
Spagnuolo, P. A., & Hoffman‐Goetz, L. (2008) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181667435 · Cited by 7
Implication of Endothelin-2 and Oxidative Stress Biomarkers in Essential Hypertension
Dhawan, V. (2014) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000170 · Cited by 7
“F2-isoprostanes are PG isomers generated nonenzymatically through free radical-catalyzed attack of esterified arachidonic acid in cell membranes and lipoproteins and have emerged as one of the most important tools to explore the role of oxidative stress in the pathogenesis of a wide range of human diseases [15-17].”
BackgroundPhysical Activity for the Prevention of Cardiovascular Diseases
Jakovljevic, V. L., & Djordjevic, D. Z. (2017) · Serbian Journal of Experimental and Clinical Research · doi:10.1515/sjecr-2016-0049 · Cited by 7
Peek, S. F. (2008) · Elsevier eBooks · doi:10.1016/b978-141603137-6.50006-5 · Cited by 7
Aspirin in Patients with Coronary Artery Disease: Is it Simply Irresistible?
Nair, G. V., Davis, C. J., McKenzie, M. E., Lowry, D. R., & Serebruany, V. L. (2001) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1011220615447 · Cited by 7
Fluvastatin depresses the enhanced lipid peroxidation in vitamin E-deficient hamsters
Suzumura, K., Ohashi, N., Oka, K., YASUHARA, M., & Narita, H. (2001) · Free Radical Research · doi:10.1080/10715760100301311 · Cited by 7
Antithrombotic Therapies in Primary Angioplasty
Luca, G. D., & Marino, P. N. (2008) · Drugs · doi:10.2165/0003495-200868160-00005 · Cited by 6
Seccia, T. M., & Rossi, G. P. (2005) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360500295600 · Cited by 6
Smyth, E. M., & FitzGerald, G. A. (2003) · Elsevier eBooks · doi:10.1016/b978-012124546-7/50528-3 · Cited by 6
Self-citationVitrac, H., Hauville, C., Collin, F., Couturier, M., Thérond, P., Delaforge, M., Rémita, S., Jore, D., & Gardès-Albert, M. (2005) · Free Radical Research · doi:10.1080/10715760500092543 · Cited by 6
“In vivo, arachidonate serves as the precursor of the prostaglandins, prostacyclins, thromboxanes and leukotrienes [4,5,6], potent intercellular mediators that control a variety of complex processes.”
BackgroundIsoprostanes in the Assessment of Oxidant Stress In Vivo
Reilly, M. P., Praticò, D., Lanken, P. N., Delanty, N., Rockach, J., Lawson, J. A., & FitzGerald, G. A. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-253-1_6 · Cited by 6
Self-citationGeraci, G., Sorce, A., Zanoli, L., Cuttone, G., Calabrese, V., Pallotti, F., Paternò, V., Ferrara, P., Domínguez, L. J., Polosa, R., et al. (2025) · Life · doi:10.3390/life15030401 · Cited by 7
“Discussion 2 α There is experimental evidence that oxidative stress contributes to the pathogenesis of hypertension [3,11,12], and previous studies have investigated the potential role of 8-iso-PGF 2 α in the process of atherosclerosis and cardiovascular diseases [7–10 , 22].”
InfluentialBierl, C., Forgione, M. A., & Loscalzo, J. (2006) · Developments in cardiovascular medicine · doi:10.1007/0-387-29553-4_4 · Cited by 5
Chapter 22 Lipids and atherosclerosis
Tabas, I. A. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)36024-1 · Cited by 5
Antioxidant Activity of Plicatin B on Cultured Human Microvascular Endothelial Cells Exposed to H2O2
Lubrano, V., Boni, G. A., L’Abbate, A., & Turchi, G. (2007) · Drug and Chemical Toxicology · doi:10.1080/01480540701522148 · Cited by 5
Gao, Y., Xu, R., Liu, H., Jia, S., Zhang, Y., Meng, X., & Gong, J. (2025) · Journal of Chromatography B · doi:10.1016/j.jchromb.2025.124552 · Cited by 4
Naruse, R., Takebayashi, K., Morita, K., Aso, Y., & Inukai, T. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-114 · Cited by 4
The Relation Between Carotid Plaque Echogenicity and Oxidative Stress Marker 8-iso-Prostaglandin F2α
Nassar, H., Furukado, S., Tanaka, M. R., Miwa, K., Okazaki, S., Sakaguchi, M., Mochizuki, H., & Kitagawa, K. (2012) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2011.11.016 · Cited by 4
Plasma 8-Isoprostane as a Biomarker and Applications to Cardiovascular Disease
de Faria, A. P., Modolo, R., & Moreno, H. (2016) · Springer eBooks · doi:10.1007/978-94-007-7678-4_31 · Cited by 4
Davı̀, G., Santilli, F., & Vazzana, N. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00035-3 · Cited by 4
Health from Herbs? Antioxidant Studies on Selected Lamiaceae Herbs in vitro and in Humans
Nurmi, A. (2008) · Työväentutkimus Vuosikirja · Cited by 4
Jj, S., Hoorntje, J. C. A., Miedema, K., & van Oeveren, W. (2004) · PubMed Central · Cited by 4
Plasma 8-Isoprostane as a Biomarker and Applications to Cardiovascular Disease
de Faria, A. P., Modolo, R., & Moreno, H. (2015) · Springer eBooks · doi:10.1007/978-94-007-7741-5_31-1 · Cited by 3
Santoso, P., Bakta, I. M., Manuaba, I. B. P., & Satriyasa, B. K. (2018) · Bali Medical Journal · doi:10.15562/bmj.v8i1.1143 · Cited by 3
BASELINE DIENE CONJUGATION IN LDL LIPIDS: AN INDICATOR OF CIRCULATING OXIDIZED LDL
Ahotupa, M. O., & Vasankari, T. J. (2001) · Elsevier eBooks · doi:10.1016/b978-0-444-50957-4.50006-5 · Cited by 3
Biochemical and Epidemiological Studies of Early-Onset and Late-Onset Pre-Eclampsia
Wikström, A. (2007) · Uppsala University Publications (Uppsala University) · Cited by 3
Microvascular Angina in Different Clinical Conditions: Diabetes and the Metabolic Syndrome
Tritto, I., Zuchi, C., & Ambrosio, G. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4838-8_13 · Cited by 2
“Isoprostanes are generated by non-enzymatic oxidation of lipids; some of them, like 8-epi-PGF-2 a , are biologically active, and may induce vasoconstriction and platelet aggregation [ 44 ] .”
BackgroundBiomarkers and Biological Indicators of Change
Lampe, J. W., & Rock, C. L. (2001) · Elsevier eBooks · doi:10.1016/b978-012193155-1/50012-x · Cited by 2
Malinin, A. I., Eisert, R. M., Atar, D., Баркаган, З. С., & Serebruany, V. L. (2002) · Heart Drug · doi:10.1159/000063427 · Cited by 2
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation
Lattanzio, S., Santilli, F., Vitale, G., Caruso, R., Davì, V., Rosa, S. D., Vazzana, N., Ciabattoni, G., Mansueto, S., & Davı̀, G. (2009) · Thrombosis Research · doi:10.1016/j.thromres.2009.06.010 · Cited by 2
The Effect of Amlodipine on Oxidative Stress in Patients with Type 2 Diabetes
Takebayashi, K., Naruse, R., Aso, Y., & Inukai, T. (2010) · SRX Medicine · doi:10.3814/2010/326840 · Cited by 2
“5 mg/day) on urinary 8-iso-prostaglandin F2α (8-isoPGF2α), a marker of systemic oxidative stress [5, 6], in patients with hypertension and type 2 diabetes complicated by diabetic nephropathy, but a significant decrease in 8-isoPGF2α was not observed [7].”
BackgroundOxidative Stress and Diseases: Current Topics and Perspective with Clinical Application in Japan
Ichiishi, E., Ohtake, T., Satoh, K., & Kohgo, Y. (2016) · Journal of Aging Science · doi:10.4172/2329-8847.1000161 · Cited by 2
“Volume 4 • Issue 3 • 1000161 J Aging Sci, an open access journal ISSN: 2329-8847 Isoprostaneα F2 -III Isoprostaneα F2 -III is non-enzymatically produced from blood LDL and cell surface phospholipid by direct oxidation of arachidonic acid by free radials [40].”
BackgroundVaziri, N. D., James, R., Roberts, K., Won, D., Pruthi, S., & Kurtovic, S. (2006) · Cited by 2
Cyclo-exygenase-1 and cyclo-oxygenase-2 and cardiovascular vascular system
Lettino, M., Cantù, F., & Mariani, M. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80154-7 · Cited by 2
ASSESSMENT OF OXIDATIVE STRESS IN EARLY AND LATE ONSET PRE-ECLAMPSIA AMONG GHANAIAN WOMEN.
Tetteh, P. M., Adu‐Bonsaffoh, K., Antwi‐Boasiako, C., Antwi, D. A., Gyan, B., & Obed, S. A. (2015) · PubMed Central · Cited by 2
Santilli, F., Simeone, P., Liani, R., & Davı̀, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_82 · Cited by 2
Dietary factors that affect carotenoid bioavailability
Hof, K. H. V. H. (1999) · doi:10.18174/196585 · Cited by 2
Abudu, N., Miller, J. J., & Levinson, S. S. (2004) · Advances in clinical chemistry · doi:10.1016/s0065-2423(04)38001-7 · Cited by 3
Systemic markers of inflammation – are they useful predictive tools in coronary artery disease?
Damås, J. K., & Aukrust, P. (2006) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430600970645 · Cited by 2
“Although some previous studies have shown that biomarkers for oxidative stress may correlate to CAD (23,24), several other studies including the paper of Ruef et al.”
ResultIsoprostanes: Are They More Than Physiopathological Biomarkers of Lipid Peroxidation?
Cracowski, J., & Baguet, J.-P. (2003) · Circulation · doi:10.1161/01.cir.0000077640.74263.82 · Cited by 2
Smyth, E. M., & FitzGerald, G. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374145-5.00150-9 · Cited by 2
Self-citationKahal, H. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 2
Riccobene, R., Arsena, R., Mulè, G., Vaccaro, F., Altieri, C., Tornese, F., Ocello, A., Cerasola, G., & Cottone, S. (2010) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11311980-000000000-00000 · Cited by 1
John, G. W., Colpaert, F. C., & Valentin, J. P. (1998) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.1998.tb00358.x · Cited by 1
Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients
Lai, M.-Y., Chao, Y., Lee, P.-C., & Lee, S. (2005) · Cited by 1
Metadata
- Authors
- Patrono, C., & FitzGerald, G. A.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 1997-11
- Volume
- 17
- Issue
- 11
- Pages
- 2309-2315
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2087724955
- Cited by
- 453
- References
- 61
- Citations by year
- 2026: 1 · 2025: 3 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 6 · 2016: 9 · 2015: 11 · 2014: 8 · 2013: 10 · 2012: 15
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Arteriosclerosis Thrombosis and Vascular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bayer
- Wellcome Trust
- European Commission
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P50HL054500, 1P50HL54500)
- National Center for Research Resources (MO1-RR-00040, M01RR000040)
- Topics
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- isoprostanes, lipid peroxidation, oxidative stress, arachidonic acid metabolism, atherothrombosis, urinary biomarkers, cardiovascular risk factors, smoking, diabetes mellitus, hypercholesterolemia, ischemia-reperfusion injury, lipid peroxidation inhibitors, dose-finding
- MeSH terms
- Antioxidants, Arteriosclerosis, Cardiovascular Diseases, Diabetes Mellitus, Free Radicals, Humans, Hyperlipidemias, Immunoassay, Indicator Dilution Techniques, Gas Chromatography-Mass Spectrometry, Platelet Aggregation, Prostaglandins F, Risk Factors, Thrombosis, Vasoconstrictor Agents, Lipid Peroxidation, Dinoprost, Biomarkers, Oxidative Stress, F2-Isoprostanes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review